Seeing the gene therapy: application of gene gun technique to transfect and decolour pigmented rat skin with human agouti signalling protein cDNA.
We developed a gene gun method for the transfer of human agouti signalling protein (ASP) cDNA to alter rat skin colour in vivo. Human ASP cDNA was cloned into a modified cytomegalovirus plasmid and delivered to the skin of Long-Evans rats by gene gun bombardment. Skin pigmentation, body weight and blood sugar of ASP cDNA-transfected rats were recorded against the control group, which were injected with plasmids encoding for green fluorescent protein. The treated skin showed lighter skin colour after 3 days of ASP gene transfection. This depigmentation effect was most prominent on day 14 and the skin gradually returned to its original pigmentation by day 28. Successful transfection of ASP gene in skin and hair follicles, as well as downregulation of melanocortin-1 receptor (MC1R) and tyrosinase expression upon treatment, was confirmed using immunohistochemistry and Western blot analysis. Body weight and blood sugar in the treated rats did not show statistically significant differences as compared to control groups. These observations demonstrate that gene transfer using the gene gun method can induce high cutaneous ASP production and facilitate a switch from dark to fair colour without systemic pleiotropic effects. Such a colour switch may be that ASP is acting in a paracrine fashion. In addition, this study verifies that ASP exerts its functions by acting as an independent ligand that downregulates the melanocyte MC1R and tyrosinase protein in an in vivo system. Our result offers new, interesting insights about the effect of ASP on pigmentation, providing a novel approach to study the molecular mechanisms underlying skin melanogenesis.
Yang
C-H
CH
Department of Dermatology, Chang Gung Memorial Hospital, Taipei, Taiwan.
Shen
S-C
SC
Lee
J C
JC
Wu
P-C
PC
Hsueh
S-F
SF
Lu
C-Y
CY
Meng
C-T
CT
Hong
H-S
HS
Yang
L-C
LC
D054366:Agouti Signaling Protein; D000818:Animals; D019470:Biolistics; D018076:DNA, Complementary / Q000008:administration & dosage*; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis / Q000235:genetics*; D008297:Male; D014442:Monophenol Monooxygenase / Q000032:analysis; D051381:Rats; D020318:Rats, Long-Evans; D044102:Receptor, Melanocortin, Type 1 / Q000032:analysis; D012867:Skin / Q000737:chemistry; D012880:Skin Pigmentation / Q000235:genetics*; D019076:Transgenes; D014404:Tubulin / Q000032:analysis
D054366:Agouti Signaling Protein; D018076:DNA, Complementary; D036341:Intercellular Signaling Peptides and Proteins; D044102:Receptor, Melanocortin, Type 1; D014404:Tubulin; D014442:Monophenol Monooxygenase